Publications by authors named "Donna Yu"

Claim this Profile
D
Discovery of novel modulators for the PPARα (peroxisome proliferator activated receptor α): Potential therapies for nonalcoholic fatty liver disease.
Donna D Yu, Gregg Van Citters, Hongzhi Li, Brian M Stoltz, Barry M Forman

Bioorg Med Chem· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The G-protein-coupled bile acid receptor Gpbar1 (TGR5) protects against renal inflammation and renal cancer cell proliferation and migration through antagonizing NF-κB and STAT3 signaling pathways.
Jia Su, Qiqi Zhang, Hui Qi, Linlin Wu, Yuanqiang Li, Donna Yu

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel inverse agonists of estrogen-related receptors ERRγ and ERRβ.
Donna D Yu, Janice M Huss, Hongzhi Li, Barry M Forman

Bioorg Med Chem· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice.
Lili Ding, Kyle M Sousa, Lihua Jin, Bingning Dong, Byung-Wook Kim, Donna Yu

Hepatology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel FXR (farnesoid X receptor) modulators: Potential therapies for cholesterol gallstone disease.
Donna D Yu, Sreenath S Andrali, Hongzhi Li, Min Lin, Wendong Huang

Bioorg Med Chem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway.
Cong Guo, Hui Qi, Yingjie Yu, Qiqi Zhang, Jia Su, Donna Yu

Front Pharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway.
Cong Guo, Jia Su, Zhijun Li, Rui Xiao, Jianxun Wen, Donna Yu

Oncotarget· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereoselective synthesis, biological evaluation, and modeling of novel bile acid-derived G-protein coupled bile acid receptor 1 (GP-BAR1, TGR5) agonists.
Donna D Yu, Kyle M Sousa, Daniell L Mattern, Jeffrey Wagner, Xianghui Fu

Bioorg Med Chem· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPBAR1/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells.
Guiyu Lou, Xiaoxiao Ma, Xianghui Fu, Zhipeng Meng, Wenyu Zhang, Donna Yu

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of trisubstituted-pyrazol carboxamide analogs as novel and potent antagonists of farnesoid X receptor.
Donna D Yu, Wenwei Lin, Barry M Forman, Taosheng Chen

Bioorg Med Chem· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discovery.
Donna D Yu, Wenwei Lin, Taosheng Chen, Barry M Forman

Bioorg Med Chem· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis.
Wei-Dong Chen, Donna Yu, Barry M Forman, Wendong Huang, Yan-Dong Wang

Hepatology· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An improved synthesis of 6α-ethylchenodeoxycholic acid (6ECDCA), a potent and selective agonist for the Farnesoid X Receptor (FXR).
Donna Yu, Daniell L Mattern, Barry M Forman

Steroids· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FXR protects lung from lipopolysaccharide-induced acute injury.
Lisheng Zhang, Tao Li, Donna Yu, Barry M Forman, Wendong Huang

Mol Endocrinol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice.
Yan-Dong Wang, Wei-Dong Chen, Donna Yu, Barry M Forman, Wendong Huang

Hepatology· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription.
Wei-Dong Chen, Yan-Dong Wang, Lisheng Zhang, Steven Shiah, Meihua Wang, Donna Yu

Hepatology· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.
Yan-Dong Wang, Wei-Dong Chen, Meihua Wang, Donna Yu, Barry M Forman

Hepatology· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of an agonist ligand for estrogen-related receptors ERRbeta/gamma.
Donna D Yu, Barry Marc Forman

Bioorg Med Chem Lett· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple and efficient production of (Z)-4-hydroxytamoxifen, a potent estrogen receptor modulator.
Donna D Yu, Barry M Forman

J Org Chem· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis